Ipsoflog

Piroxicam, the active ingredient in Ipsoflog, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular use. It treats rheumatoid arthritis, osteoarthritis, musculoskeletal pain and other inflammatory conditions in adult patients. It is indicated for the management of inflammatory and painful musculoskeletal disorders, providing symptomatic relief and reducing swelling.

GNH USA supplies Ipsoflog as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to European Union quality standards and is manufactured under strict Good Manufacturing Practice (GMP) conditions.

Piroxicam is an NSAID that reduces inflammation by inhibiting cyclooxygenase enzymes, and it is used for several musculoskeletal and joint disorders. - Rheumatoid arthritis: alleviates joint pain, swelling and stiffness in chronic inflammatory disease. - Osteoarthritis: reduces pain and improves joint function in degenerative joint disease. - Musculoskeletal pain: provides rapid relief of acute pain from injuries or overuse. - Inflammatory conditions: diminishes inflammation in soft‑tissue disorders such as bursitis or tendinitis.

Piroxicam may be associated with a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or abdominal pain. - Headache: mild to moderate headache. - Dizziness: transient vertigo or light‑headedness. - Injection site reactions: pain, erythema or swelling at the intramuscular site.

Serious or Rare Side Effects: - Severe gastrointestinal ulceration or bleeding. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When using piroxicam injectable, clinicians should consider several precautionary measures to minimize risks. - Assess renal function: evaluate kidney status before initiating therapy. - Monitor hepatic function: check liver enzymes periodically during treatment. - Use lowest effective dose: limit exposure to reduce gastrointestinal and cardiovascular risk. - Avoid in patients with active peptic ulcer disease: contraindicated due to ulcer risk. - Caution in elderly patients: increased susceptibility to adverse effects. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Piroxicam can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - ACE inhibitors or diuretics: may reduce renal function.

Moderate Interactions (Monitor Closely): - Lithium: piroxicam may raise lithium levels. - Methotrexate: possible increased toxicity. - Cyclosporine: enhanced nephrotoxic effect.